Severe acute respiratory infections, such as community-acquired pneumonia, hospital-
acquired pneumonia, and ventilator-associated pneumonia, constitute frequent and lethal …

(1-3)-beta-D-glucan (BDG) is an almost panfungal marker (absent in zygomycetes and most
cryptococci), which can be successfully used in screening and diagnostic testing in patients …

Background and Purpose: There has been a significant increase in the burden of fungal
diseases in the last few decades which has imposed a global threat to the health of humans …

Pneumocystis jirovecii pneumonia (PCP) is an important cause of morbidity in
immunocompromised patients, with a higher mortality in non-HIV than in HIV patients. P …

Because of the vast numbers of COVID-19 infections, IFD in COVID-19 critical-care patients
represents a significant burden of disease, even if incidences are less than 5%. Optimal …

Pneumocystis jirovecii is an uncultivable fungal pathogen responsible for Pneumocystis
pneumonia (PCP) in immunocompromised patients, the physiopathology of which is only …

The development of combination antiretroviral therapies (cARTs) in the mid-1990s has
dramatically modified the clinical presentation of critically ill, HIV-infected patients. Most …

Introduction Fungal infections are increasingly encountered in clinical practice due to more
favorable environmental conditions and increasing prevalence of immunocompromised …

Introduction. Pneumocystis jirovecii pneumonia (PCP) is a severe disease affecting
immunocompromised patients. Diagnosis is difficult due to the low sensitivity of direct …

Background: Serum (1, 3)-β-D-glucan (BG) testing is increasingly being used in the
diagnostic armamentarium for invasive fungal diseases. Given its high sensitivity, some …